Note however that two other independent breast cancer risk variants in this region (tagged by rs1685760913 and a 1.3 kb insertion/deletion49) are also believed to target IGFBP5, but we did not find evidence for interactions between these variants and current EPT use. This evidence concerns the gene IGFBP5 and breast carcinoma.